Lv4
490 积分 2021-06-15 加入
A comprehensive evaluation of exposure–response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasis
2天前
已完结
Review article: the use of potentially hepatotoxic drugs in patients with liver disease
3天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
24天前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1个月前
已完结
Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis
2个月前
已完结
Artificial intelligence and machine learning for clinical pharmacology
2个月前
已完结
Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists
2个月前
已完结
Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology
2个月前
已完结
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia
2个月前
已完结
Comparability of biosimilar romiplostim with originator: Protein characterization, animal pharmacodynamics and pharmacokinetics
2个月前
已完结
皖公网安备34019202002308
